Zai Lab (ZLAB) Other Operating Expenses (2023)

Zai Lab (ZLAB) posted quarterly Other Operating Expenses of $10.0 million for Q2 2023.

Zai Lab (ZLAB) Other Operating Expenses (2023) Analysis & Trends

Zai Lab (ZLAB) has reported Other Operating Expenses for 1 consecutive years, with $10.0 million the latest figure, recorded in Q2 2023.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $10.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $10.0 million (changed N/A YoY) and the FY2023 annual result came in at $10.0 million, changed N/A from the prior year.
  • Other Operating Expenses was little changed at $10.0 million in Q2 2023 per ZLAB's latest filing.
  • Over the last five years, Other Operating Expenses for ZLAB reached as high as $10.0 million in Q2 2023 and fell as low as $10.0 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 10.00 Mn